Natco, Other Generics Ask U.S. High Court To Lift Stay On Copaxone Sales
This article was originally published in PharmAsia News
Executive Summary
India's Natco Pharma and global makers of generic drugs filed a formal petition with the U.S. Supreme Court to lift an injunction against them pending the outcome of a patent dispute with Israel's Teva Pharmaceutical Industries.